Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: A meta-analysis

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 224-230

  Wang, Yuyao ^a   Zhang, Weili ^a   Li, Shaohua ^a   Song, Weihua ^a   Chen, Jingzhou ^a   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Coronary artery disease; Genetics; Monocyte chemoattractant protein 1

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MONOCYTE CHEMOTACTIC PROTEIN 1;

ALLELE; ARTICLE; ATHEROSCLEROSIS; CAUCASIAN; CCR 2 GENE; CORONARY ARTERY DISEASE; GENE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MCP 1 GENE; PRIORITY JOURNAL; RISK FACTOR; SAMPLE SIZE; SYSTEMATIC REVIEW;

ALLELES; CHEMOKINE CCL2; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; PUBLICATION BIAS; RECEPTORS, CCR2; RESEARCH DESIGN; RISK FACTORS; SAMPLE SIZE;

EID: 84860423696     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.07.116     Document Type: Article

References (54)

1. Murray C.J., Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997, 349:1436-1442.
2. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
3. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 2000, 86:3J-8J. discussion 8J-9J.
4. Sanders S.K., Crean S.M., Boxer P.A., Kellner D., LaRosa G.J., Hunt S.W. Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J Immunol 2000, 165:4877-4883.
5. Cushing S.D., Berliner J.A., Valente A.J., et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990, 87:5134-5138.
6. Murphy P.M. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev 1996, 7:47-64.
7. Schecter A.D., Calderon T.M., Berman A.B., et al. Human vascular smooth muscle cells possess functional CCR5. J Biol Chem 2000, 275:5466-5471.
8. Charo I.F., Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ Res 2004, 95:858-866.
9. Gonzalez-Quesada C., Frangogiannis N.G. Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes. Curr Atheroscler Rep 2009, 11:131-138.
10. Rovin B.H., Lu L., Saxena R. A novel polymorphism in MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999, 259:344-348.
11. Szalai C., Duba J., Prohaszka Z., et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518G/G genotype in CAD patients. Atherosclerosis 2001, 158:233-239.
12. Ortlepp J.R., Vesper K., Mevissen V., et al. Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J Mol Med 2003, 81:363-367.
13. Simeoni E., Winkelmann B.R., Hoffmann M.M., et al. Association of Rantes G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 2004, 25:1438-1446.
14. Gonzalez P., Alvarez R., Batalla A., et al. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun 2001, 2:191-195.
15. Zhong C., Luzhan Z., Genshan M., Jiahong W., Xiaoli Z., Qi Q. Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease. Mol Biol Rep 2010, 37:7-12.
16. Tabara Y., Kohara K., Yamamoto Y., et al. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 2003, 26:677-683.
17. Hwang S.Y., Cho M.L., Park B., et al. Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease. Eur J Immunogenet 2002, 29:413-416.
18. Pola R., Flex A., Gaetani E., et al. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 2004, 39:1249-1252.
19. Bjarnadottir K., Eiriksdottir G., Aspelund T., Gudnason V. Examination of genetic effects of polymorphism in the MCP-1 and CCR2 genes on MI in the Icelandic population. Atherosclerosis 2006, 188:341-346.
20. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
21. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
22. Cermakova Z., Petrkova J., Arakelyan A., et al. The MCP-1 2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Int J Immunol 2005, 32:315-318.
23. McDermott D.H., Yang Q., Kathiresan S., et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 2005, 112:1113-1120.
24. Bucova M., Lietava J., Mrazek F., et al. Association of chronic stable angina pectoris with MCP-1-2518 A/G single nucleotide polymorphism in the Slovak population. Clin Chim Acta 2008, 392:71-72.
25. Jemaa R., Rolbani H., Kallel A., et al. Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Clin Chim Acta 2008, 390:122-125.
26. Cam S.F., Sekuri C., Sagcan A., et al. Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease. Scand J Clin Lab Invest 2008, 68:801-805.
27. Bucova M., Lietava J., Penz P., et al. Association of MCP-1-2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension. Mediators Inflamm 2009, 2009:390951.
28. Bucova M., Lietava J., Mrazek F., et al. The MCP-1-2518 (A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population. Bratisl Lek Listy 2009, 110:385-389.
29. Zhang X., Han Y., Kang J., Yan C. A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population. Clin Chim Acta 2009, 403:241-243.
30. van Wijk D.F., van Leuven S.I., Sandhu M.S., et al. Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2010, 30:1460-1466.
31. Petrkova J., Cermakova Z., Drabek J., Lukl J., Petrek M. CC chemokine receptor (CCR)2 polymorphism in Czech patients with myocardial infarction. Immunol Lett 2003, 88:53-55.
32. Apostolakis S., Baritaki S., Kochiadakis G.E., Igoumenidis N.E., Panutsopulos D., Spandidos D.A. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. Thromb Res 2007, 119:63-71.
33. Morgan T.M., Krumholz H.M., Lifton R.P., Spertus J.A. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 2007, 297:1551-1561.
34. Dow D.J., McMahon A.D., Gray I.C., Packard C.J., Groot P.H. CCR2 and coronary artery disease: a woscops substudy. BMC Res Notes 2010, 3:31.
35. Karaali Z.E., Sozen S., Yurdum M., et al. Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population. Mol Biol Rep 2010, 37:3615-3619.
36. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
37. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316:1491-1493.
38. WTCCC Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
39. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357:443-453.
40. Aukrust P., Halvorsen B., Yndestad A., et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008, 28:1909-1919.
41. Gu L., Okada Y., Clinton S.K., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998, 2:275-281.
42. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897.
43. Morgan T.M., Coffey C.S., Krumholz H.M. Overestimation of genetic risks owing to small sample sizes in cardiovascular studies. Clin Genet 2003, 64:7-17.
44. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., Hirschhorn J.N. Metaanalysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003, 33:177-182.
45. Raff G.L., Abidov A., Achenbach S., et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr 2009, 3:122-136.
46. Arbab-Zadeh A., Hoe J. Quantification of coronary arterial stenoses by multidetector CT angiography in comparison with conventional angiography methods, caveats, and implications. JACC Cardiovasc Imaging 2011, 4:191-202.
47. Ioannidis J.P.A., Ntzani E.E., Trikalinos T.A., Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309.
48. Li W., Xu J., Wang X., Chen J., Zhang C., Sun K., Hui R. Cyclooxygenase-2 (COX-2) G-765C is a protective factor for coronary artery disease but not for ischemic stroke: a meta-analysis. Atherosclerosis 2009, 207:492-495.
49. Wang M., Lang X., Zou L., Huang S., Xu Z. Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies. Atherosclerosis 2011, 214:377-385.
50. Daly A.K., Day C.P. Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol 2001, 52:489-499.
51. Ioannidis J.P., Boffetta P., Little J., et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 2008, 37:120-132.
52. Braunersreuther V., Mach F., Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007, 97:714-721.
53. de Lemos J.A., Morrow D.A., Sabatine M.S., et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003, 107:690-695.
54. Cipollone F., Marini M., Fazia M., et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001, 21:327-334.